Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

How 1 Rheumatology Patient Changed the History of a Disease

Jason Liebowitz, MD, FACR  |  Issue: November 2024  |  November 10, 2024

In August 2019, Michael received a call from Dr. Ombrello, who had been working with David Beck to find patients whose clinical histories fit the pattern of what would come to be called VEXAS. Many aspects of Michael’s history, including his fevers, cytopenias, chondritis and response to glucocorticoids, indicated that he may have the condition, which prompted genetic testing of the blood samples he had provided at the NIH in 2011.

Genetic Mutation Found

Dr. Ombrello explained to Michael that he’d been found to have the UBA1 gene mutation and that he likely had VEXAS. The NIH team asked if he could come back to Bethesda for more testing to help researchers learn about the condition.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Michael’s wife, Nancy, recalled to me how incredibly sick he was by this time; he was dependent on blood transfusions and was too weak to tolerate a bone marrow transplant. But Michael was determined to help improve the scientific knowledge of this new disease.

“He knew he was going to be a guinea pig,” Nancy told me, “but he wanted to do whatever he could to help.” This was in keeping with Michael’s giving nature; years before, when Nancy’s mother had become physically disabled, he insisted that she move into the family’s home, where she spent the last two decades of her life.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The day before Michael was scheduled to fly to the NIH, he was still in the hospital and was told he might die if he left.

“They topped him off with a few transfusions, he signed himself out, and we got home at 11 p.m. for an 8 o’clock flight the next morning,” Nancy recounted.

Michael stayed at the NIH for more than a week and gave innumerable vials of blood, which he had in short supply.

Outcome & Legacy

When he returned to Chicago, his disease continued to progress. He had several more hospitalizations, including one in early December 2019. It was at that time that his oldest daughter Laura shared with him the news that she was pregnant. Michael was overcome with emotion as he thought of Laura becoming a mother for the first time, while realizing that he would likely never get a chance to meet this child.

Not long after learning of his daughter’s pregnancy, Michael’s doctors organized a family meeting and explained that there was simply nothing else that they could do. Michael entered into hospice care and traveled with Nancy back to his home.

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsOpinionOther Rheumatic ConditionsSpeak Out Rheum Tagged with:David BeckDr. Amanda OmbrelloMichael MilovicVEXASVEXAS syndrome

Related Articles

    Tips for Transitioning Patients from Pediatric to Adult Rheumatology Care

    October 14, 2021

    Approximately 50% of young adult patients with childhood-onset rheumatic diseases become lost to follow-up within the first year of transferring to adult rheumatology care, mirroring the statistics of other subspecialties.1,2 One of the challenges cited most consistently by young adult patients and their families relates to differences between rheumatology care delivery in the pediatric and…

    Dana Robochek / shutterstock.com

    VEXAS: A Newly Identified & Vexing Myeloid-Driven Inflammation

    December 14, 2020

    A large, international team of rheumatologists, geneticists, hematologists and other researchers has discovered a severe inflammatory syndrome linked to an acquired genetic mutation in the bone marrow of older men. The X-linked syndrome, they found, is caused by a somatic mutation in myeloid stem cells that hobbles the master regulator of a pathway tasked with…

    This CT scan demonstrates a mass causing partial occlusion of the esophagus.

    Case Report: An Adult-Onset Still’s Disease Mimic

    July 18, 2019

    A 53-year-old man was hospitalized for pericarditis, abdominal lymphadenopathy of unknown origin and non-bloody diarrhea. He was admitted for four days, and then he was discharged home without incident. Two months after his initial presentation, he was readmitted for the evaluation of several new issues, including symmetric arthralgias, hypovolemia with associated electrolyte abnormalities and concurrent…

    Highlights from the ACR Review Course 2022

    December 6, 2022

    PHILADELPHIA—At ACR Convergence 2022, the much-anticipated ACR Review Course featured talks from eight experts. Topics reflected the heterogeneity of our field and included Sjögren’s disease, spondyloarthritis (SpA), osteoarthritis (OA), paraneoplastic rheumatic syndromes, metabolic bone disease, statin myopathy, Raynaud’s phenomenon and autoinflammatory syndrome. Here, I share highlights from this comprehensive, six-hour session. Sjögren’s Disease Sara S….

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences